Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Elite Health Systems (EHSI) Cash from Financing Activities (2016 - 2025)

Elite Health Systems' Cash from Financing Activities history spans 14 years, with the latest figure at $1.4 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at $1.4 million for Q4 2025, up 21.16% from a year ago — trailing twelve months through Dec 2025 was $3.7 million (down 22.66% YoY), and the annual figure for FY2025 was $3.7 million, down 22.66%.
  • Cash from Financing Activities for Q4 2025 was $1.4 million at Elite Health Systems, down from $1.9 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $1.9 million in Q3 2025 to a low of -$89000.0 in Q1 2021.
  • The 3-year median for Cash from Financing Activities is $1.1 million (2024), against an average of $1.1 million.
  • Peak annual rise in Cash from Financing Activities hit 80.1% in 2025, while the deepest fall reached 72.84% in 2025.
  • Year by year, Cash from Financing Activities stood at -$89000.0 in 2021, then surged by 1364.04% to $1.1 million in 2024, then increased by 21.16% to $1.4 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $1.4 million, $1.9 million, and $474000.0 for Q4 2025, Q3 2025, and Q1 2025 respectively.